Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 2 |
2009 | 1 |
2010 | 3 |
2011 | 3 |
2012 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
HER2: biology, detection, and clinical implications.
Arch Pathol Lab Med. 2011 Jan;135(1):55-62. doi: 10.5858/2010-0454-RAR.1.
Arch Pathol Lab Med. 2011.
PMID: 21204711
Free PMC article.
Review.
Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts.
Rimawi MF, Wiechmann LS, Wang YC, Huang C, Migliaccio I, Wu MF, Gutierrez C, Hilsenbeck SG, Arpino G, Massarweh S, Ward R, Soliz R, Osborne CK, Schiff R.
Rimawi MF, et al.
Clin Cancer Res. 2011 Mar 15;17(6):1351-61. doi: 10.1158/1078-0432.CCR-10-1905. Epub 2010 Dec 7.
Clin Cancer Res. 2011.
PMID: 21138857
Free PMC article.
Item in Clipboard
Molecular profiles of progesterone receptor loss in human breast tumors.
Creighton CJ, Kent Osborne C, van de Vijver MJ, Foekens JA, Klijn JG, Horlings HM, Nuyten D, Wang Y, Zhang Y, Chamness GC, Hilsenbeck SG, Lee AV, Schiff R.
Creighton CJ, et al.
Breast Cancer Res Treat. 2009 Mar;114(2):287-99. doi: 10.1007/s10549-008-0017-2. Epub 2008 Apr 19.
Breast Cancer Res Treat. 2009.
PMID: 18425577
Free PMC article.
Item in Clipboard
Forkhead box A1 (FOXA1) is a key mediator of insulin-like growth factor I (IGF-I) activity.
Potter AS, Casa AJ, Lee AV.
Potter AS, et al.
J Cell Biochem. 2012 Jan;113(1):110-21. doi: 10.1002/jcb.23333.
J Cell Biochem. 2012.
PMID: 21882221
Free PMC article.
Item in Clipboard
High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.
Litzenburger BC, Creighton CJ, Tsimelzon A, Chan BT, Hilsenbeck SG, Wang T, Carboni JM, Gottardis MM, Huang F, Chang JC, Lewis MT, Rimawi MF, Lee AV.
Litzenburger BC, et al.
Clin Cancer Res. 2011 Apr 15;17(8):2314-27. doi: 10.1158/1078-0432.CCR-10-1903. Epub 2010 Dec 22.
Clin Cancer Res. 2011.
PMID: 21177763
Free PMC article.
Item in Clipboard
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.
Creighton CJ, Massarweh S, Huang S, Tsimelzon A, Hilsenbeck SG, Osborne CK, Shou J, Malorni L, Schiff R.
Creighton CJ, et al.
Cancer Res. 2008 Sep 15;68(18):7493-501. doi: 10.1158/0008-5472.CAN-08-1404.
Cancer Res. 2008.
PMID: 18794137
Free PMC article.
Item in Clipboard
Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes.
Rimawi MF, Shetty PB, Weiss HL, Schiff R, Osborne CK, Chamness GC, Elledge RM.
Rimawi MF, et al.
Cancer. 2010 Mar 1;116(5):1234-42. doi: 10.1002/cncr.24816.
Cancer. 2010.
PMID: 20082448
Free PMC article.
Item in Clipboard
Cite
Cite